UN stocks billions of syringes for COVID-19 vaccine

UNICEF said it was purchasing five million safety boxes for used syringes.

Geneva, Switzerland:

The United Nations said on Monday it will stockpile a billion syringes worldwide by the end of 2021, which will be used to administer any future vaccine against the coronavirus.

UNICEF, the United Nations Children’s Fund, has said it aims to get 520 million syringes in its warehouses by the end of this year, to ensure the countries’ initial supply before the vaccine.

“The world will need several syringes as vaccine supplements,” UNICEF said in a statement.

UNICEF said it was purchasing five million safety boxes for used syringes.

According to AFP’s tally based on official sources, the number of confirmed coronavirus cases worldwide was 40 million on Monday. More than 1.1 million deaths have been reported worldwide.

UNICEF Executive Director Henrietta Four said: “The global vaccination against Kovid-19 will be one of the greatest collective endeavors in human history and we must move forward the most. quickly possible ”.

“By the end of the year, we will already have over half a billion syringes deployed, where they can be deployed quickly and inexpensively.

The international pool for the purchase, production and distribution of coronavirus vaccines created by the World Health Organization (WHO) will be used by syringes.

Covax is managed by the Gavi Vaccine Alliance, which will reimburse UNICEF for the syringes.

A public-private partnership, Gavi helps immunize half of the world’s children against certain deadly diseases on the planet.

Syringes have a five-year shelf life and are shipped by sea instead of vaccines, which are heat sensitive and transported faster by air cargo.

Billions of syringes are the top of the 620 million that UNICEF will buy for other immunization programs against diseases like measles and typhoid.

WHO says 42 candidate vaccines are currently being tested in humans, 10 of which are in the third and final phase of mass testing.

Another 156 are being developed in laboratories for human testing.

Typically, about 10% of vaccine candidates are tested.

(This story is not edited by NDTV employees and automatically generated from a syndicated feed.)

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: